SCHEMBL25985111

SCHEMBL25985111

c1ccc(-c2ccc(N(c3ccccc3)c3ccc4c(c3)oc3cc(-c5nc(-c6ccccc6)nc(-n6c7ccccc7c7ccccc76)n5)ccc34)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.32
MAPT P10636 3/20 0.32
PDE5A O76074 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
GLA P06280 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
RECQL P46063 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
ABCG2 Q9UNQ0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25980610 0.95 CHEK2 (0.31) KDM1AMAPTPDE5AALDH1A1HPGD
SCHEMBL25979972 0.92 KDM4E (0.36) KDM1AMAPTPDE5AALDH1A1HPGD
SCHEMBL15763820 0.92 TSPO (0.35) KDM1AMAPTALDH1A1HPGDKDM4E
SCHEMBL26779217 0.91 KDM4E (0.37) KDM1AMAPTPDE5AALDH1A1HPGD
SCHEMBL22802114 0.90 HCRTR1 (0.33) KDM1AMAPTPDE5AALDH1A1HPGD
SCHEMBL22802258 0.90 HCRTR1 (0.33) KDM1AMAPTPDE5AALDH1A1HPGD
SCHEMBL22802121 0.90 HCRTR1 (0.35) KDM1AMAPTPDE5AALDH1A1HPGD
SCHEMBL22802122 0.90 HCRTR1 (0.35) KDM1AMAPTPDE5AALDH1A1HPGD
SCHEMBL22802120 0.89 HCRTR1 (0.33) KDM1AMAPTALDH1A1HPGDKDM4E
SCHEMBL25979569 0.89 KDM4E (0.38) MAPTPDE5AALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 KDM1A 533/4885MAPT 1428/4885PDE5A 3555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.